参考文献/References:
[1]Wen PY,Huse JT.2016 World Health Organization Classification of Central Nervous System Tumors[J].Continuum,2017,23(6):1531-1547.[2]Patel NP,Lyon KA,Huang JH.The effect of race on the prognosis of the glioblastoma patient:a brief review[J].Neurological research,2019,41(11):967-971.[3]Alexander BM,Cloughesy TF.Adult Glioblastoma[J].Journal of clinical oncology:official journal of the American Society of Clinical Oncology,2017,35(21):2402-2409.[4]Alifieris C,Trafalis DT.Glioblastoma multiforme:Pathogenesis and treatment[J].Pharmacology&Therapeutics,2015(152):63-82.[5]Franceschi E,Minichillo S,Brandes AA.Pharmacotherapy of Glioblastoma:Established Treatments and Emerging Concepts[J].CNS Drugs,2017,31(8):675-684.[6]Geletneky K,Hajda J,Angelova AL,et al.Oncolytic H-1 Parvovirus Shows Safety and Signs of Immunogenic Activity in a First Phase I/IIa Glioblastoma Trial[J].Mol Ther,2017,25(12):2620-2634.[7]Liau LM,Ashkan K,Tran DD,et al.Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma[J].J Transl Med,2018,29,16(1):179.[8]Levine AJ.p53,the cellular gatekeeper for growth and division[J].Cell,1997,88(3):323-331.[9]Karimian A,Ahmadi Y,Yousefi B.Multiple functions of p21 in cell cycle,apoptosis and transcriptional regulation after DNA damage[J].DNA Repair(Amst),2016(42):63-71.[10]Han N,Yuan F,Xian P,et al.GADD45a Mediated Cell Cycle Inhibition Is Regulated By P53 In Bladder Cancer[J].Onco Targets Ther,2019(12):7591-7599.[11]Ohki R,Nemoto J,Murasawa H,et al.Reprimo,a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase[J].J Biol Chem,2000,275(30):22627-22630.[12]Chen J.The Cell-Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression[J].Cold Spring Harb Perspect Med,2016,6(3):a26104.[13]Amelio I,Melino G.The p53 family and the hypoxia-inducible factors(HIFs):determinants of cancer progression[J].Trends Biochem Sci,2015,40(8):425-434.[14]Zhan R,Xu K,Pan J,et al.Long noncoding RNA MEG3 mediated angiogenesis after cerebral infarction through regulating p53/NOX4 axis[J].Biochem Biophys Res Commun,2017, 490(3):700-706.[15]Biasoli D,Sobrinho MF,Da FA,et al.Glioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy[J].Oncogenesis,2014,3(10):e123.[16]Park CM,Park MJ,Kwak HJ,et al.Induction of p53-mediated apoptosis and recovery of chemosensitivity through p53 transduction in human glioblastoma cells by cisplatin[J].Int J Oncol,2006,28(1):119-125.[17]Voce DJ,Bernal GM,Wu L,et al.Temozolomide Treatment Induces lncRNA MALAT1 in an NF-kappaB and p53 Codependent Manner in Glioblastoma[J].Cancer Research,2019,79(10):2536-2548.[18]Zhang Y,Dube C,Gibert MJ,et al.The p53 Pathway in Glioblastoma[J].Cancers(Basel),2018,10(9):297. [19]Lin Y,Liao K,Miao Y,et al.Role of asparagine endopeptidase in mediating wild-type p53 inactivation of glioblastoma[J].J Natl Cancer Inst,2019.[20]Brook L,Palade P,Maatough A,et al.Hairless regulates p53 target genes to exert tumor suppressive functions in glioblastoma[J].Journal of cellular biochemistry,2019,120(1):533-543.[21]Zhu H,Wang H,Huang Q,et al.Transcriptional Repression of p53 by PAX3 Contributes to Gliomagenesis and Differentiation of Glioma Stem Cells[J].Frontiers in molecular neuroscience,2018(11):187.[22]Xu D,Liu A,Wang X,et al.Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells[J].Cell Death&Disease,2018,9(5):514.[23]Zhao WH,Wu SQ,Zhang YD.Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L[J].Int J Mol Med,2013,32(1):101-107.[24]Wu N,Lin X,Zhao X,et al.MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways[J].Br J Cancer,2013,109(11):2853-2863.[25]Chen Y,Hu X,Li Y,et al.Ars2 promotes cell proliferation and tumorigenicity in glioblastoma through regulating miR-6798-3p[J].Sci Rep,2018,8(1):15602.[26]Zhao H,Peng R,Liu Q,et al.The lncRNA H19 interacts with miR-140 to modulate glioma growth by targeting iASPP[J].Arch Biochem Biophys,2016(610):1-7.[27]He Z,Wang Y,Huang G,et al.The lncRNA UCA1 interacts with miR-182 to modulate glioma proliferation and migration by targeting iASPP[J].Arch Biochem Biophys,2017(623-624):1-8.[28]Canon J,Osgood T,Olson SH,et al.The MDM2 Inhibitor AMG 232 Demonstrates Robust Antitumor Efficacy and Potentiates the Activity of p53-Inducing Cytotoxic Agents[J].Mol Cancer Ther,2015,14(3):649-658.[29]Gluck WL,Gounder MM,Frank R,et al.Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53wild-type solid tumors or multiple myeloma[J].Investigational New Drugs,2019:1-13.[30]Chen C,Nelson LJ,Avila MA,et al.Mitogen-Activated Protein Kinases(MAPKs)and Cholangiocarcinoma:The Missing Link[J].Cells,2019,8(10):E1172.[31]Johnson GL,Lapadat R.Mitogen-activated protein kinase pathways mediated by ERK,JNK,and p38 protein kinases[J].Science,2002,298(5600):1911-1912.[32]Liu Z,Wang F,Zhou Z,et al.Alisertib induces G2/M arrest,apoptosis,and autophagy via PI3K/Akt/mTOR- andp38 MAPK-mediated pathways in human glioblastoma cells[J].American Journal of Translational Research,2017,9(3):845-873.[33]Wang R,Deng D,Shao N,et al.Evodiamine activates cellular apoptosis through suppressing PI3K/AKT and activating MAPK in glioma[J].Onco Targets Ther,2018(11):1183-1192.[34]Vitucci M,Karpinich NO,Bash RE,et al.Cooperativity between MAPK and PI3K signaling activation is required for glioblastoma pathogenesis[J].Neuro Oncol,2013,15(10):1317-1329.[35]Ngo MT,Harley B.Perivascular signals alter global gene expression profile of glioblastoma and response to temozolomide in a gelatin hydrogel[J].Biomaterials,2019(198):122-134.[36]Yang P,Kang W,Pan Y,et al.Overexpression of HOXC6 promotes cell proliferation and migration via MAPK signaling and predicts a poor prognosis in glioblastoma[J].Cancer Manag Res,2019(11):8167-8179.[37]Mu N,Gu J,Liu N,et al.PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways[J].Theranostics,2018,8(6):1527-1539.[38]Li Q,Miao Z,Wang R,et al.Hesperetin Induces Apoptosis in Human Glioblastoma Cells via p38 MAPK Activation[J].Nutr Cancer,2019:1-8.[39]Jean S,Kiger AA.Classes of phosphoinositide 3-kinases at a glance[J].J Cell Sci,2014,127(Pt 5):923-928.[40]Revathidevi S,Munirajan AK.Akt in cancer:Mediator and more[J].Semin Cancer Biol,2019.[41]Borrie S C,Brems H,Legius E,et al.Cognitive Dysfunctions in Intellectual Disabilities:The Contributions of the Ras-MAPK and PI3K-AKT-mTOR Pathways[J].Annu Rev Genomics Hum Genet,2017(18):115-142.[42]Zhang ZZ,Qin XH,Zhang J.MicroRNA-183 inhibition exerts suppressive effects on diabetic retinopathy by inactivating BTG1-mediated PI3K/Akt/VEGF signaling pathway[J].Am J Physiol Endocrinol Metab,2019,316(6):E1050-E1060.[43]Seo YS,Kang OH,Kong R,et al.Polygalacin D induces apoptosis and cell cycle arrest via the PI3K/Akt pathway in non-small cell lung cancer[J].Oncol Rep,2018,39(4):1702-1710.[44]Chen YR,Liu MT,Chang YT,et al.Epstein-Barr virus latent membrane protein 1 represses DNA repair through the PI3K/Akt/FOXO3a pathway in human epithelial cells[J].J Virol,2008,82(16):8124-8137.[45]Zheng Q,Diao S,Wang Q,et al.IL-17A promotes cell migration and invasion of glioblastoma cells via activation of PI3K/AKT signaling pathway[J].J Cell Mol Med,2019,23(1):357-369.[46]Zhong C,Chen Y,Tao B,et al.LIM and SH3 protein 1 regulates cell growth and chemosensitivity of human glioblastoma via the PI3K/AKT pathway[J].BMC Cancer,2018,18(1):722.[47]Zhang J,Zhang J,Qiu W,et al.MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma[J].J Neurooncol,2018,139(3):547-562.[48]Zhang G,Chen L,Khan AA,et al.miRNA-124-3p/neuropilin-1(NRP-1)axis plays an important role in mediating glioblastoma growth and angiogenesis[J].Int J Cancer,2018,143(3):635-644.[49]Chang JH,Hwang YH,Lee DJ,et al.MicroRNA-203 Modulates the Radiation Sensitivity of Human Malignant Glioma Cells[J].Int J Radiat Oncol Biol Phys,2016,94(2):412-420.[50]Lv D,Jia F,Hou Y,et al.Histone Acetyltransferase KAT6A Upregulates PI3K/AKT Signaling through TRIM24 Binding[J].Cancer Res,2017,77(22):6190-6201.[51]Ando Y,Inada-Inoue M,Mitsuma A,et al.Phase I dose-escalation study of buparlisib(BKM120),an oral pan-class I PI3K inhibitor,in Japanese patients with advanced solid tumors[J].Cancer Sci,2014,105(3):347-353.[52]Siebel C,Lendahl U.Notch Signaling in Development,Tissue Homeostasis,and Disease[J].Physiol Rev,2017,97(4):1235-1294.[53]Nowell CS,Radtke F.Notch as a tumour suppressor[J].Nat Rev Cancer,2017,17(3):145-159.[54]Espinoza I,Miele L.Notch inhibitors for cancer treatment[J].Pharmacology&Therapeutics,2013,139(2):95-110.[55]Aster JC,Pear WS,Blacklow SC.The Varied Roles of Notch in Cancer[J].Annu Rev Pathol,2017(12):245-275.[56]El Hindy N,Keyvani K,Pagenstecher A,et al.Implications of Dll4-Notch signaling activation in primary glioblastomamultiforme[J].Neuro Oncol,2013,15(10):1366-1378.[57]Cenciarelli C,Marei HE,Zonfrillo M,et al.The interference of Notch1 target Hes1 affects cell growth,differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets[J].Oncotarget,2017,8(11):17873-17886.[58]Huang SX,Zhao ZY,Weng GH,et al.Upregulation of miR-181a suppresses the formation of glioblastoma stem cells by targeting the Notch2 oncogene and correlates with good prognosis in patients with glioblastoma multiforme[J].Biochem Biophys Res Commun,2017,486(4):1129-1136.[59]Deng J,Liu AD,Hou GQ,et al.N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling[J].J Exp Clin Cancer Res,2019,38(1):2.[60]Ulasov IV,Mijanovic O,Savchuk S,et al.TMZ regulates GBM stemness via MMP14-DLL4-Notch3 pathway[J].Int J Cancer,2019.[61]El HN,Keyvani K,Pagenstecher A,et al.Implications of Dll4-Notch signaling activation in primary glioblastoma multiforme[J].Neuro Oncol,2013,15(10):1366-1378.[62]Sun T,Patil R,Galstyan A,et al.Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talk[J].Cancer Res,2019,79(6):1239-1251.[63]Han B,Wang R,Chen Y,et al.QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway[J].Cell Oncol(Dordr),2019.[64]Fan Y,Xue W,Schachner M,et al.Honokiol Eliminates Glioma/Glioblastoma Stem Cell-Like Cells Via JAK-STAT3 Signaling and Inhibits Tumor Progression by Targeting Epidermal Growth Factor Receptor[J].Cancers(Basel),2018,11(1):22.[65]Mastrella G,Hou M,Li M,et al.Targeting APLN/APLNR Improves Antiangiogenic Efficiency and Blunts Proinvasive Side Effects of VEGFA/VEGFR2 Blockade in Glioblastoma[J].Cancer Res,2019,79(9):2298-2313.[66]Maugeri G,D’Amico AG,Rasa DM,et al.Caffeine Effect on HIFs/VEGF Pathway in Human Glioblastoma Cells Exposed to Hypoxia[J].Anticancer Agents Med Chem,2018,18(10):1432-1439.[67]Wang T,Chen W,Wu J.H2-P,a honokiol derivative,exerts anti-angiogenesis effects via c-MYC signaling pathway in glioblastoma[J].J Cell Biochem,2018,119(4):3142-3148.[68]Huang W,Zhong Z,Luo C,et al.The miR-26a/AP-2alpha/Nanog signaling axis mediates stem cell self-renewal and temozolomide resistance in glioma[J].Theranostics,2019,9(19):5497-5516.[69]Luo W,Yan D,Song Z,et al.miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/beta-catenin signaling via targeting SOX2[J].Life Sci,2019(226):98-106.[70]Hartheimer JS,Park S,Rao SS,et al.Targeting Hyaluronan Interactions for Glioblastoma Stem Cell Therapy[J].Cancer Microenviron,2019,12(1):47-56.[71]Jiang Y,Zhou J,Hou D,et al.Prosaposin is a biomarker of mesenchymal glioblastoma and regulates mesenchymal transition through the TGF-beta1/Smad signaling pathway[J].J Pathol,2019,249(1):26-38.[72]Ma H,Li T,Tao Z,et al.NKCC1 promotes EMT-like process in GBM via RhoA and Rac1 signaling pathways[J].J Cell Physiol,2019,234(2):1630-1642.[73]Shukla A,Gupta P,Singh R,et al.Glycolytic inhibitor 2-Deoxy-d-Glucose activates migration and invasion in glioblastoma cells through modulation of the miR-7-5p/TFF3 signaling pathway[J].Biochem Biophys Res Commun,2018,499(4):829-835.[74]Paluch EK,Aspalter IM,Sixt M.Focal Adhesion-Independent Cell Migration[J].Annu Rev Cell Dev Biol,2016,32(1):469-490.[75]Natarajan M,Hecker TP,Gladson CL.FAK signaling in anaplastic astrocytoma and glioblastoma tumors[J].Cancer J,2003,9(2):126-133.[76]Chen HH,Chen CW,Chang YY,et al.Preliminary crystallographic characterization of the Grb2 SH2 domain in complex with a FAK-derived phosphotyrosyl peptide[J].Acta Crystallogr Sect F Struct Biol Cryst Commun,2010,66(Pt 2):195-197.[77]Liu BY,He XY,Xu C,et al.Peptide and Aptamer Decorated Delivery System for Targeting Delivery of Cas9/sgRNA Plasmid To Mediate Antitumor Genome Editing[J].ACS Appl Mater Interfaces,2019,11(27):23870-23879.